Explore
Validate
LearnABIN2480413
antibody from antibodies-online
Targeting: CD44
CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1
Western blot
ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2480413 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CD44 (CD44) antibody
- Antibody type
- Monoclonal
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 156-3C11
- Vial size
- 25 μg
Submitted references CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen).
Ateroid in the treatment of dementia: results of a clinical trial.
Olsson E, Honeth G, Bendahl PO, Saal LH, Gruvberger-Saal S, Ringnér M, Vallon-Christersson J, Jönsson G, Holm K, Lövgren K, Fernö M, Grabau D, Borg A, Hegardt C
BMC cancer 2011 Sep 29;11:418
BMC cancer 2011 Sep 29;11:418
Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen).
Alves CS, Yakovlev S, Medved L, Konstantopoulos K
The Journal of biological chemistry 2009 Jan 9;284(2):1177-89
The Journal of biological chemistry 2009 Jan 9;284(2):1177-89
Ateroid in the treatment of dementia: results of a clinical trial.
Conti L, Placidi GF, Cassano GB
Modern problems of pharmacopsychiatry 1989;23:76-84
Modern problems of pharmacopsychiatry 1989;23:76-84
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
